Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AMPHAMPH
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AMPHASTAR PHARMACEUTICALS IN

GOLDMAN SACHS GROUP INC holds 505,360 shares of AMPH (AMPHASTAR PHARMACEUTICALS IN), worth $10.2M as of 2026-Q2. The position was increased (+53.4% shares). AMPH represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$10.2M

Current Shares

505,360

Total Value Change

-$5.7M

Total Shares Change

+77,525

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
505,360
+53.4%
$10.2M0.0%$20.18
39
2026-Q1
Decreased
329,388
-40.8%
$6.5M0.0%$19.83
0
2025-Q4
Increased
556,709
+130.8%
$14.9M0.0%$27.00
45
2025-Q3
Decreased
241,228
-32.3%
$6.4M0.0%$26.92
0
2025-Q2
Decreased
356,250
-12.4%
$8.2M0.0%$23.08
0
2025-Q1
Decreased
406,712
-4.9%
$11.8M0.0%$28.43
0
2024-Q4
New
427,835
-
$15.9M0.0%$36.84
39

Other major holders of AMPH: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used